Biomarkers & monitoring

Monday September 12, 2022 from 11:35 to 13:05

Room: E

216.7 The immunohistochemical expression of endothelial activation biomarkers is a potential tool to predict kidney allograft outcomes

Award Winner

Tainá V Sandes-Freitas, Brazil has been granted the Emerging Economy Congress Scientific Award

Tainá V Sandes-Freitas, Brazil

Professor
Clinical Medicine
Universidade Federal do Ceará

Abstract

The immunohistochemical expression of endothelial activation biomarkers is a potential tool to predict kidney allograft outcomes

André C Teixeira1,2,5, Fábio Távora4,5, Ester A Mourão2, Gabriel B Castaldelli2, Thiago Belmino A.B Evangelista2, Ronaldo M Esmeraldo3, Tainá Sandes-Freitas1,3.

1Medical Sciences Postgraduation Program, Department of Clinical Medicine, Federal University of Ceara, Fortaleza, Brazil; 2Faculty of Medicine Unichristus, Fortaleza, Brazil; 3Division of Transplantation, Hospital Geral de Forteleza, Fortaleza, Brazil; 4Department of Pathology, Federal University of Ceará, Fortaleza, Brazil; 5ARGOS Laboratory, Fortaleza, Brazil

Background and Objective: Few reports assessed biomarkers of endothelial activation in kidney allograft biopsies using immunohistochemistry (IHC). This study aimed to analyze the IHC expression of Caveolin-1 (Cav), Von Willebrand Factor (Vwf), and T-Cadherin (Cad) in for-cause allograft biopsies diagnosed as Interstitial Fibrosis and Tubular Atrophy (IF/TA) of unknown etiology and evaluate its association with graft loss.

Methods: This was a retrospective single-center cohort study including kidney biopsies performed in a single center between January 2013 and December 2017, whose histological, laboratory and clinical analysis concluded for IF/TA of unknown etiology. Samples with antibody-mediated changes were excluded. Patients were followed for three years after the biopsy or until graft loss/death.

Results: Seventy-one (71) samples from 66 patients were included. Eighteen (25.4%) patients lost their grafts, mainly due to chronic rejection (33.3%). Cav and Cad were not associated with graft loss. Vwf had good accuracy to predict graft failure (AUC 0.637, 95%CI 0.486-0.788, p = 0.101). The presence of more than 10% of Vwf positivity in the microvasculature (Vwf > 10%) was associated with reduced death-censored graft survival (58.2% versus 85.4%, p = 0.006). The multivariate analysis showed that Vwf > 10% was an independent risk factor for graft loss (HR = 2.88, 95%CI 1.03-8.02, p = 0.043).

Conclusion: Vwf might be an additional tool to predict allograft outcomes in kidney transplant recipients with IF/TA of unknown etiology, probably reflecting immune endothelial activation.



© 2024 TTS 2022